Sun Pharma rises as its arm acquires Zalicus Pharmaceuticals

14 Oct 2015 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 886.50, up by 4.05 points or 0.46% from its previous closing of Rs. 882.45 on the BSE.

The scrip opened at Rs. 886.00 and has touched a high and low of Rs. 894.00 and Rs. 885.00 respectively. So far 76851 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.70 on 07-Apr-2015 and a 52 week low of Rs. 792.00 on 17-Oct-2014.

Last one week high and low of the scrip stood at Rs. 933.70 and Rs. 875.00 respectively. The current market cap of the company is Rs. 213829.21 crore.

The promoters holding in the company stood at 54.71% while Institutions and Non-Institutions held 31.51% and 13.78% respectively.

Sun Pharmaceutical Industries’ US subsidiary - Taro Pharmaceuticals has acquired Canada's Zalicus Pharmaceuticals, a company engaged in the development of a pain management drug candidate coded Z944. This acquisition is aimed at strengthening Taro’s focus on proprietary drugs and expanding beyond its forte in dermatology drugs.

Taro Pharmaceuticals made cash payment of about Rs 25 crore in addition to issuing a non-interest bearing, limited recourse promissory note of an equal amount with maturity date of July 1, 2017.

Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. The company provides high quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries worldwide.

 

 

Sun Pharma Inds. Share Price

1795.30 -9.65 (-0.53%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×